Potential new therapy approaches to reverse kidney damage identified

Cell plasticity program resulting from kidney damage can be targeted to reverse kidney disease and fibrosis, new research suggests. The study demonstrated the importance of an embryonic cellular process called EMT (epithelial-to-mesenchymal transition) as a potential therapeutic target for reversing kidney disease. Embryos cannot develop without EMT.